John McCarty Joins Formex, LLC As Scientific Advisor

SAN DIEGO, Aug. 14, 2014 /PRNewswire/ -- Formex, LLC ("Formex"), a leader in pharmaceutical development and manufacturing, announced that Mr. John McCarty has joined Formex as  Scientific Advisor and Science Advisory Board Member.

Mr. McCarty has over 30 years of experience in drug product development within the pharmaceutical and biotechnology industries.   Mr. McCarty has broad expertise in the development of all major dosage forms and is an inventor on over 17 U.S. and foreign patents. 

Prior to Formex; Mr. McCarty has held several senior management positions in Research and Development at Key Pharmaceuticals, Schering–Plough, and Pharmavene (acquired by Shire) and also served as Vice-President of Formulation Development at Azo Pharma.

"John brings a wealth of knowledge and expertise in formulation  development, operations, and manufacturing for both clinical and commercial products to Formex.  We are extremely pleased to work with John as our Senior Consultant and Member of our Scientific Advisory Board," stated Dr. J. Blair West, Chief Scientific Officer of Formex.  "John is well prepared to contribute to Formex  as we continue to grow and expand in our capabilities and market presence."

About Formex LLC.

Formex LLC ("Formex"), The Formulation Experts, is a leading contract development and manufacturing organization focusing on oral and topical dosage forms.  Formex specializes in bioavailability enhancement and controlled release technologies, such as hot melt extrusion, spray drying, fluid bed processing, and liquid/semi-solid filled hard capsules.